Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m‐AMSA

Ronenn Roubenoff, Richard J. Jones, Judith E. Karp, Mary Betty Stevens

Research output: Contribution to journalArticlepeer-review

Abstract

We describe 2 patients in whom a sustained remission of longstanding rheumatoid arthritis occurred with treatment for acute myelogenous leukemia (cytosine arabinoside, daunorubicin, and m‐AMSA), even though both illnesses had been refractory to therapy with standard disease‐modifying agents. These 2 patients represent the first successful treatment of rheumatoid disease using such an approach.

Original languageEnglish (US)
Pages (from-to)1187-1190
Number of pages4
JournalArthritis & Rheumatism
Volume30
Issue number10
DOIs
StatePublished - Oct 1987

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m‐AMSA'. Together they form a unique fingerprint.

Cite this